Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients.

Yan QinShiyu JiangPeng LiuJianliang YangSheng YangXiaohui HeShengyu ZhouLin GuiJing LinXinhua DuYuting YiYan SunYuan-Kai Shi

Published in: Cancer management and research (2020)

This study presents the characteristics of TP53-mutated DLBCL and implies a potential benefit of locoregional treatment in limited-stage DLBCL patients with TP53 mutations.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
combination therapy
climate change
replacement therapy